Inventor · disambiguated record
Jason Samuel Tan
Also filed as: TAN JASON · TAN JASON SAMUEL
5 granted patents·12 pending applications·72 citations·filing 2008–2024
81Inventor score
Files withACUITAS THERAPEUTICS INC7ADMARE THERAPEUTICS SOC3PAJOUHESH HASSAN3ZALICUS PHARMACEUTICALS LTD3UNIV FRASER SIMON1
Top patents by PatentIndex Score
17 records- 0192US8133998B2Bicyclic pyrimidine derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2008·Granted Mar 13, 2012·51 cites·42 claims
- 0291US12129223B2Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2022·Granted Oct 29, 2024·4 cites·26 claims
- 0384US8377968B2N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2009·Granted Feb 19, 2013·7 cites·2 claims
- 0481US9096522B2N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2013·Granted Aug 4, 2015·5 cites·11 claims
- 0581US8569344B2N-piperidinyl acetamide derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2012·Granted Oct 29, 2013·5 cites·5 claims
- 0672US2025188020A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0765US2024423914A1Amide containing lipidsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0862US2024423915A1Lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0962US2024417370A1Lipids for use in lipid nanoparticle formulationsACUITAS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1060US2024239790A17-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 1160US2024246960A17-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 1259US2025059131A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1357US2025092002A1Fluorinated cationic lipids for use in lipid nanoparticlesACUITAS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1454US2025326754A1DNA-PK Inhibitor Compounds and Uses ThereofADMARE THERAPEUTICS SOC·Filed 2023·Application pending·0 cites
- 1551US2009298834A14-(aminomethyl)cyclohexanamine derivatives as calcium channel blockersPAJOUHESH HASSAN·Filed 2009·Application pending·0 cites
- 1649US2016175315A1N-piperidinyl acetamide derivatives as calcium channel blockersZALICUS PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
- 1733US2018312493A1Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses ThereforUNIV FRASER SIMON·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →